解释-2-应用和前景 Clinical trial AMPs Indication Deliever Status identifiers Daptomyein Bacterial skin infections Intravenous Approved NCT01211470 Vancomycin Staphylococcal infections Intravenous Approved NCT00175370 Dalbavancin(B1397,Dalvance.Xydalba) Acute bacterial skin infections Intravenous Approved NCT03233438 Colistin Multidrug-resistant Gram-negative infections Intravenous Approved NCT03397914 Antibacterial and anti-inflammatory drugs 成本高 MP Antiviral dngs Skin acre and medical cosmetology 稳定性差 Medical tissue engincenng Anticancer drug Drug delivery syster 生物毒性 Protein Pept Lett.2019:26(2):79-87.解释-2 --- 应用和前景 成本高 稳定性差 生物毒性 严禁复制